Health Assessment Questionnaire disability progression in early rheumatoid arthritis: Systematic review and analysis of two inception cohorts

[1]  Anna M. Monk,et al.  Self-help interventions for symptoms of depression, anxiety and psychological distress in patients with physical illnesses: a systematic review and meta-analysis. , 2014, Clinical psychology review.

[2]  T. Kawada.  The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. , 2014, Rheumatology.

[3]  J. Gottenberg,et al.  Subclinical atherosclerosis in Behcet's disease: A systematic review and meta-analysis. , 2016, Seminars in arthritis and rheumatism.

[4]  Y. Kwan,et al.  Association between helplessness, disability, and disease activity with health-related quality of life among rheumatoid arthritis patients in a multiethnic Asian population , 2014, Rheumatology International.

[5]  J. Done,et al.  Trajectories of functional limitation in early rheumatoid arthritis and their association with mortality. , 2013, Rheumatology.

[6]  M. Hochberg,et al.  New treatments for osteoarthritis , 2013, Current opinion in rheumatology.

[7]  Jaime Rosenthal,et al.  Availability of consumer prices from US hospitals for a common surgical procedure. , 2013, JAMA internal medicine.

[8]  David Moher,et al.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement , 2013, International Journal of Technology Assessment in Health Care.

[9]  Craig Whittington,et al.  Introducing GRADE across the NICE clinical guideline program. , 2013, Journal of clinical epidemiology.

[10]  Bernadette A. Thomas,et al.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[11]  N. Clement,et al.  Predicting the cost-effectiveness of total hip and knee replacement: a health economic analysis. , 2013, The bone & joint journal.

[12]  Gerald Gartlehner,et al.  [GRADE guidelines: 10. Considering resource use and rating the quality of economic evidence]. , 2013, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[13]  A. Mushlin,et al.  Appropriateness criteria and elective procedures--total joint arthroplasty. , 2012, The New England journal of medicine.

[14]  L. Bearne,et al.  Are Patients Meeting the Updated Physical Activity Guidelines? Physical Activity Participation, Recommendation, and Preferences Among Inner-City Adults With Rheumatic Diseases , 2012, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[15]  J. Cobb,et al.  The Global Economic Cost of Osteoarthritis: How the UK Compares , 2012, Arthritis.

[16]  M. Tikly,et al.  Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis , 2012, Scandinavian journal of rheumatology.

[17]  J. Katz,et al.  The cost-effectiveness of total joint arthroplasty: a systematic review of published literature. , 2012, Best practice & research. Clinical rheumatology.

[18]  A. Distante,et al.  Socioeconomic burden of total joint arthroplasty for symptomatic hip and knee osteoarthritis in the Italian population: A 5‐year analysis based on hospitalization records , 2012, Arthritis care & research.

[19]  M. Westby.  Rehabilitation and total joint arthroplasty. , 2012, Clinics in geriatric medicine.

[20]  S. Bae,et al.  Do patients with elderly-onset rheumatoid arthritis have severe functional disability? , 2012, Seminars in arthritis and rheumatism.

[21]  C. Mok,et al.  Concurrent psychiatric disorders are associated with significantly poorer quality of life in patients with rheumatoid arthritis , 2012, Scandinavian journal of rheumatology.

[22]  M. Hotopf,et al.  Gender differences in prevalence of depression among patients receiving palliative care: The role of dependency , 2012, Palliative medicine.

[23]  P. Tugwell,et al.  Ottawa panel evidence-based clinical practice guidelines for aerobic walking programs in the management of osteoarthritis. , 2012, Archives of physical medicine and rehabilitation.

[24]  S. Bierma-Zeinstra,et al.  Productivity costs and medical costs among working patients with knee osteoarthritis , 2012, Arthritis care & research.

[25]  R. Fordham,et al.  The economic benefit of hip replacement: a 5-year follow-up of costs and outcomes in the Exeter Primary Outcomes Study , 2012, BMJ Open.

[26]  C. Cooper,et al.  Genetic contribution to radiographic severity in osteoarthritis of the knee , 2012, Annals of the rheumatic diseases.

[27]  Gordon Guyatt,et al.  American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee , 2012, Arthritis care & research.

[28]  R. Goeree,et al.  The excess burden of osteoarthritis in the province of Ontario, Canada. , 2012, Arthritis and rheumatism.

[29]  A. Woolf,et al.  The need to address the burden of musculoskeletal conditions. , 2012, Best practice & research. Clinical rheumatology.

[30]  J. Groothoff,et al.  Social support and psychological distress in rheumatoid arthritis: a 4-year prospective study , 2012, Disability and rehabilitation.

[31]  M. Dibonaventura,et al.  Impact of self-rated osteoarthritis severity in an employed population: Cross-sectional analysis of data from the national health and wellness survey , 2012, Health and Quality of Life Outcomes.

[32]  C. Helmick,et al.  The Impact of Osteoarthritis in the United States: A Population-Health Perspective , 2012, The American journal of nursing.

[33]  Sharon-Lise Normand,et al.  Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[34]  Jarkko Leskinen,et al.  The incidence of knee arthroplasty for primary osteoarthritis grows rapidly among baby boomers: a population-based study in Finland. , 2012, Arthritis and rheumatism.

[35]  R. Akehurst,et al.  The cost-effectiveness of celecoxib vs diclofenac in the treatment of osteoarthritis in the UK; an update to the NICE model using data from the CONDOR trial , 2012, Journal of medical economics.

[36]  C. Bombardier,et al.  The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic review , 2011, Annals of the rheumatic diseases.

[37]  C. Carswell.  Essentials of Pharmacoeconomics , 2008, PharmacoEconomics.

[38]  Alan Brennan,et al.  Modelling in Health Economic Evaluation , 2000, PharmacoEconomics.

[39]  P. Hansen,et al.  Cost-effectiveness of nonpharmacologic, nonsurgical interventions for hip and/or knee osteoarthritis: systematic review. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[40]  J. Chancellor,et al.  The Burden of Arthritis and Nonsteroidal Anti-Inflammatory Treatment , 2012, PharmacoEconomics.

[41]  C. Phillips,et al.  Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK , 2012, PharmacoEconomics.

[42]  H. Ruchlin,et al.  A Review of Health-Utility Data for Osteoarthritis , 2012, PharmacoEconomics.

[43]  B. O'brien,et al.  Cost-effectiveness acceptability curves and a reluctance to lose , 2012, PharmacoEconomics.

[44]  J. Jordan,et al.  Defining osteoarthritis: a moving target. , 2012, Osteoarthritis and cartilage.

[45]  L. Trupin,et al.  Differences in activity limitation, pain intensity, and global health in patients with rheumatoid arthritis in Sweden and the USA: a 5-year follow-up , 2011, Scandinavian journal of rheumatology.

[46]  D. Pereira,et al.  The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review. , 2011, Osteoarthritis and cartilage.

[47]  C Kent Kwoh,et al.  Objective physical activity measurement in the osteoarthritis initiative: Are guidelines being met? , 2011, Arthritis and rheumatism.

[48]  J. Herbold,et al.  Rehabilitation Following Total Knee Replacement, Total Hip Replacement, and Hip Fracture: A Case-Controlled Comparison , 2011, Journal of geriatric physical therapy.

[49]  D. Hunter,et al.  Emerging drugs for osteoarthritis , 2011, Expert opinion on emerging drugs.

[50]  G. Kingsley,et al.  Quality of life and the outcome of established rheumatoid arthritis. , 2011, Best practice & research. Clinical rheumatology.

[51]  M. Drummond,et al.  Valuing Health for Clinical and Economic Decisions: Directions Relevant for Rheumatologists , 2011, The Journal of Rheumatology.

[52]  F. Berenbaum,et al.  Osteoarthritis: an update with relevance for clinical practice , 2011, The Lancet.

[53]  C. Cooper,et al.  Osteoporosis: burden, health care provision and opportunities in the EU , 2011, Archives of osteoporosis.

[54]  Lynn Casimiro,et al.  Ottawa Panel Evidence-Based Clinical Practice Guidelines for the Management of Osteoarthritis in Adults Who Are Obese or Overweight , 2011, Physical Therapy.

[55]  G. Guyatt,et al.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.

[56]  S. Reichenbach,et al.  All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study , 2011, BMJ : British Medical Journal.

[57]  F. Wolfe,et al.  Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: A longitudinal study of 18,485 patients , 2011, Arthritis care & research.

[58]  Rochelle P. Walensky,et al.  Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans , 2011, Annals of Internal Medicine.

[59]  J. Smolen,et al.  Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. , 2011, Rheumatology.

[60]  Mark Leys,et al.  Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions , 2011, International Journal of Technology Assessment in Health Care.

[61]  L. Sharma,et al.  Physical activity levels and functional performance in the osteoarthritis initiative: a graded relationship. , 2011, Arthritis and rheumatism.

[62]  R. Buchbinder,et al.  Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database. , 2011, Rheumatology.

[63]  A. Taniguchi,et al.  Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan , 2012, Rheumatology International.

[64]  Hugo Saner,et al.  Predictors of readmission and health related quality of life in patients with chronic heart failure: a comparison of different psychosocial aspects , 2011, Journal of Behavioral Medicine.

[65]  S. Øverland,et al.  The health status of nonparticipants in a population-based health study: the Hordaland Health Study. , 2010, American journal of epidemiology.

[66]  L. Keefer,et al.  Preliminary evidence supporting a framework of psychological adjustment to inflammatory bowel disease† , 2010, Inflammatory bowel diseases.

[67]  M. Hiligsmann,et al.  Glucosamine sulphate in the treatment of knee osteoarthritis: cost‐effectiveness comparison with paracetamol , 2010, International journal of clinical practice.

[68]  M. Calnan,et al.  Patient perspective of measuring treatment efficacy: The rheumatoid arthritis patient priorities for pharmacologic interventions outcomes , 2010, Arthritis care & research.

[69]  A. Migliore,et al.  Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept , 2010, Quality of Life Research.

[70]  F. Wolfe,et al.  The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study , 2010, Arthritis research & therapy.

[71]  Z. Yekta,et al.  Behavioural and clinical factors associated with depression among individuals with diabetes. , 2010, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[72]  N. Foster,et al.  The attitudes, beliefs and behaviours of GPs regarding exercise for chronic knee pain: a systematic review , 2010, BMC family practice.

[73]  Mark Lunt,et al.  Early treatment with , and time receiving , fi rst disease-modifying antirheumatic drug predicts long-term function in patients with infl ammatory polyarthritis , 2010 .

[74]  M. Ahlmén,et al.  Influence of gender on assessments of disease activity and function in early rheumatoid arthritis in relation to radiographic joint damage , 2009, Annals of the rheumatic diseases.

[75]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[76]  M. Hiligsmann,et al.  Impact of chondroitin sulphate on health utility in patients with knee osteoarthritis: towards economic analysis , 2009, Journal of medical economics.

[77]  C. Clar,et al.  The clinical effectiveness of glucosamine and chondroitin supplements in slowing or arresting progression of osteoarthritis of the knee: a systematic review and economic evaluation. , 2009, Health technology assessment.

[78]  D. Symmons,et al.  Association of Functional Outcome With Both Personal- and Area-Level Socioeconomic Inequalities in Patients With Inflammatory Polyarthritis , 2009, Arthritis and rheumatism.

[79]  A. Haines,et al.  Economic evaluation of arthritis self management in primary care , 2009, BMJ : British Medical Journal.

[80]  G. Marchesini,et al.  Predictors of health‐related quality of life in patients with chronic liver disease , 2009, Alimentary pharmacology & therapeutics.

[81]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[82]  N. Latimer,et al.  Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis , 2009, BMJ : British Medical Journal.

[83]  A David Paltiel,et al.  Cost-effectiveness of total knee arthroplasty in the United States: patient risk and hospital volume. , 2009, Archives of internal medicine.

[84]  J. Ratcliffe,et al.  Long-term clinical benefits and costs of an integrated rehabilitation programme compared with outpatient physiotherapy for chronic knee pain. , 2009, Physiotherapy.

[85]  Stefan Störk,et al.  Depression and disease severity as predictors of health-related quality of life in patients with chronic heart failure--a structural equation modeling approach. , 2009, Journal of cardiac failure.

[86]  M. Palta,et al.  Socioeconomic status and age variations in health-related quality of life: results from the national health measurement study. , 2009, The journals of gerontology. Series B, Psychological sciences and social sciences.

[87]  S. Kurtz,et al.  Future Young Patient Demand for Primary and Revision Joint Replacement: National Projections from 2010 to 2030 , 2009, Clinical orthopaedics and related research.

[88]  F. Salaffi,et al.  The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people , 2009, Health and quality of life outcomes.

[89]  M. Jarman,et al.  An Exploration of the Experiences of Young Women Living with Type 1 Diabetes , 2009, Journal of health psychology.

[90]  A. Taniguchi,et al.  The Influence of Sex on Patients with Rheumatoid Arthritis in a Large Observational Cohort , 2009, The Journal of Rheumatology.

[91]  N. Bansback,et al.  The economics of treatment in early rheumatoid arthritis. , 2009, Best practice & research. Clinical rheumatology.

[92]  G. Zlateva,et al.  Cost-utility of celecoxib use in different treatment strategies for osteoarthritis and rheumatoid arthritis from the Quebec healthcare system perspective , 2009, Journal of medical economics.

[93]  P. Sarzi-Puttini,et al.  Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: clinical outcomes. , 2009, Autoimmunity reviews.

[94]  L. Carmona,et al.  Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort , 2008, Arthritis research & therapy.

[95]  J. Mejía-Aranguré,et al.  Cost Effectiveness and Resource Allocation Cost-effectiveness Analysis for Joint Pain Treatment in Patients with Osteoarthritis Treated at the Instituto Mexicano Del Seguro Social (imss): Comparison of Nonsteroidal Anti-inflammatory Drugs (nsaids) vs. Cyclooxygenase-2 Selective Inhibitors , 2008 .

[96]  J. Kremer,et al.  Functional improvement after patients with rheumatoid arthritis start a new disease modifying antirheumatic drug (DMARD) associated with frequent changes in DMARD: the CORRONA database. , 2008, The Journal of rheumatology.

[97]  Olivier Meyer,et al.  Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study , 2008, Arthritis Research & Therapy.

[98]  M. Hochberg,et al.  Mortality in osteoarthritis. , 2008, Clinical and experimental rheumatology.

[99]  Maiwenn J Al,et al.  Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[100]  S. Bryan,et al.  Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. , 2008, Health technology assessment.

[101]  P Tugwell,et al.  OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. , 2008, Osteoarthritis and cartilage.

[102]  E. Inoue,et al.  Low disease activity state with corticosteroid may not represent 'true' low disease activity state in patients with rheumatoid arthritis. , 2007, Rheumatology.

[103]  Douglas G Altman,et al.  [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]. , 2007, Gaceta sanitaria.

[104]  S. Willich,et al.  Quality of life and cost-effectiveness of acupuncture treatment in patients with osteoarthritis pain , 2008, The European Journal of Health Economics.

[105]  S. Pocock,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.

[106]  Jonathan A C Sterne,et al.  METAN: Stata module for fixed and random effects meta-analysis , 2007 .

[107]  P. Dieppe,et al.  Economic evaluation of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain , 2007, Arthritis and rheumatism.

[108]  H. Yamanaka,et al.  Elevation of serum matrix metalloproteinase-3 as a predictive marker for the long-term disability of rheumatoid arthritis patients in a prospective observational cohort IORRA , 2007, Modern rheumatology.

[109]  C. Hill,et al.  Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use. , 2007, Seminars in arthritis and rheumatism.

[110]  T. Kvien,et al.  Measuring disability and quality of life in established rheumatoid arthritis. , 2007, Best practice & research. Clinical rheumatology.

[111]  Alexandra Ward,et al.  Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone , 2007, Current medical research and opinion.

[112]  C. Mallen,et al.  Chronic knee pain , 2007, BMJ : British Medical Journal.

[113]  M. Loyd,et al.  An economic model of long-term use of celecoxib in patients with osteoarthritis , 2007, BMC gastroenterology.

[114]  M. Suarez‐Almazor,et al.  OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. , 2007, The Journal of rheumatology.

[115]  A. Finset,et al.  Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[116]  M. Hall,et al.  Attitudes of African American and Low Socioeconomic Status White Women toward Medical Research , 2007, Journal of health care for the poor and underserved.

[117]  A. Silman,et al.  Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register , 2006, Annals of the rheumatic diseases.

[118]  J. Dekker,et al.  The cost effectiveness of behavioural graded activity in patients with osteoarthritis of hip and/or knee , 2006, Annals of the rheumatic diseases.

[119]  G. Herrero-Beaumont,et al.  EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) , 2005, Annals of the rheumatic diseases.

[120]  T. Pincus,et al.  Changes in Health Assessment Questionnaire disability scores over five years in patients with rheumatoid arthritis compared with the general population. , 2006, Arthritis and rheumatism.

[121]  A. Brennan,et al.  A prognostic model for functional outcome in early rheumatoid arthritis. , 2006, The Journal of rheumatology.

[122]  M. Drummond,et al.  Whither trial-based economic evaluation for health care decision making? , 2006, Health economics.

[123]  James Raftery,et al.  Commentary: A clinical challenge , 2006, BMJ : British Medical Journal.

[124]  G. Torrance,et al.  Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee. , 2006, The American journal of managed care.

[125]  Michael J. Green,et al.  Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. , 2006, Rheumatology.

[126]  Martin Buxton,et al.  Early assessment of the likely cost-effectiveness of a new technology: A Markov model with probabilistic sensitivity analysis of computer-assisted total knee replacement , 2006, International Journal of Technology Assessment in Health Care.

[127]  J. Katz,et al.  Total joint replacement in osteoarthritis. , 2006, Best practice & research. Clinical rheumatology.

[128]  M. Doherty,et al.  Changing life-styles and osteoarthritis: what is the evidence? , 2006, Best practice & research. Clinical rheumatology.

[129]  R. Baddoura,et al.  Severity of rheumatoid arthritis: the SEVERA study , 2006, Clinical Rheumatology.

[130]  R. Willke,et al.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[131]  R. Davey,et al.  Randomised controlled trial of the cost-effectiveness of water-based therapy for lower limb osteoarthritis. , 2005, Health Technology Assessment.

[132]  L. Persson,et al.  The development of emotional distress in 158 patients with recently diagnosed rheumatoid arthritis: a prospective 5‐year follow‐up study , 2005, Scandinavian journal of rheumatology.

[133]  L. Alfredsson,et al.  Socioeconomic status and the risk of developing rheumatoid arthritis: results from the Swedish EIRA study , 2005, Annals of the rheumatic diseases.

[134]  J. Guralnik,et al.  Prospective study of physical activity and physical function in early old age. , 2005, American journal of preventive medicine.

[135]  P. Tugwell,et al.  Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis , 2004, Annals of the rheumatic diseases.

[136]  M. Dougados,et al.  EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) , 2004, Annals of the rheumatic diseases.

[137]  J. Reginster,et al.  Total joint replacement of hip or knee as an outcome measure for structure modifying trials in osteoarthritis. , 2005, Osteoarthritis and cartilage.

[138]  L. Lynd,et al.  The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environment. , 2004, Rheumatology.

[139]  M. Drummond,et al.  Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle , 2004, BMJ : British Medical Journal.

[140]  F. Guillemin,et al.  Are there more than cross-sectional relationships of social support and support networks with functional limitations and psychological distress in early rheumatoid arthritis? the European Research on Incapacitating Diseases and Social Support Longitudinal Study. , 2004, Arthritis and rheumatism.

[141]  P. Tugwell,et al.  Percentile benchmarks in patients with rheumatoid arthritis: Health Assessment Questionnaire as a quality indicator (QI) , 2004, Arthritis research & therapy.

[142]  M. Lai,et al.  Cost-effectiveness of treatment strategies for osteoarthritis of the knee in Taiwan. , 2004, The Journal of rheumatology.

[143]  W. Gerth,et al.  Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge? , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[144]  M. Massie.  Prevalence of depression in patients with cancer. , 2004, Journal of the National Cancer Institute. Monographs.

[145]  J. Jacobs,et al.  Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. , 2004, Arthritis and rheumatism.

[146]  H. Picavet,et al.  Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study , 2004, Annals of the rheumatic diseases.

[147]  Olivier Ethgen,et al.  Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. , 2004, The Journal of bone and joint surgery. American volume.

[148]  N Benton,et al.  MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years , 2004, Annals of the rheumatic diseases.

[149]  P. Hannonen,et al.  Similar prediction of mortality by the health assessment questionnaire in patients with rheumatoid arthritis and the general population , 2004, Annals of the rheumatic diseases.

[150]  M. Shainline,et al.  Hospital, pharmacy, and outpatient costs for osteoarthritis and chronic back pain. , 2004, The Journal of rheumatology.

[151]  J. Smolen,et al.  Patients with rheumatoid arthritis in clinical care , 2004, Annals of the rheumatic diseases.

[152]  M. Sullivan,et al.  Do SF-36 summary component scores accurately summarize subscale scores? , 2004, Quality of Life Research.

[153]  M. Drummond,et al.  Towards a reference case for use in future economic evaluations of interventions in osteoarthritis. , 2003, The Journal of rheumatology. Supplement.

[154]  Arden,et al.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT) , 2003, Annals of the rheumatic diseases.

[155]  Olivier Meyer,et al.  Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis. , 2003, The Journal of rheumatology.

[156]  G. Crombez,et al.  Acceptance of pain is an independent predictor of mental well-being in patients with chronic pain: empirical evidence and reappraisal , 2003, Pain.

[157]  M. Dougados,et al.  Is time to joint replacement a valid outcome measure in clinical trials of drugs for osteoarthritis? , 2003, Rheumatic diseases clinics of North America.

[158]  J. Fries,et al.  Reduction in long-term functional disability in rheumatoid arthritis from 1977 to 1998:a longitudinal study of 3035 patients. , 2003, The American journal of medicine.

[159]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[160]  G. Kingsley,et al.  Joint damage and disability in rheumatoid arthritis: an updated systematic review. , 2003, Clinical and experimental rheumatology.

[161]  Andrea Furlan,et al.  Updated Method Guidelines for Systematic Reviews in the Cochrane Collaboration Back Review Group , 2003, Spine.

[162]  G. Naglie,et al.  The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis. , 2003, Arthritis and rheumatism.

[163]  B. Spiegel,et al.  The Cost-Effectiveness of Cyclooxygenase-2 Selective Inhibitors in the Management of Chronic Arthritis , 2003, Annals of Internal Medicine.

[164]  J. Cerhan,et al.  Health related quality of life in women with elderly onset rheumatoid arthritis. , 2003, The Journal of rheumatology.

[165]  J. Hazes.  Determinants of physical function in rheumatoid arthritis: association with the disease process. , 2003, Rheumatology.

[166]  M. Drummond,et al.  OMERACT 6 Economics Working Group report: a proposal for a reference case for economic evaluation in rheumatoid arthritis. , 2003, The Journal of rheumatology.

[167]  S. Gabriel,et al.  The cost-effectiveness of acetaminophen, NSAIDs, and selective COX-2 inhibitors in the treatment of symptomatic knee osteoarthritis. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[168]  A. Mykletun,et al.  The association between age and depression in the general population: a multivariate examination , 2003, Acta psychiatrica Scandinavica.

[169]  J. Ware.  SF-36 health survey: Manual and interpretation guide , 2003 .

[170]  J. Hay,et al.  Examining the Value and Quality of Health Economic Analyses: Implications of Utilizing the QHES , 2003, Journal of managed care pharmacy : JMCP.

[171]  F. Wolfe,et al.  Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects. , 2002, The Journal of rheumatology.

[172]  I. Hallberg,et al.  Pain and quality of life among older people with rheumatoid arthritis and/or osteoarthritis: a literature review. , 2002, Journal of clinical nursing.

[173]  J. Reginster,et al.  The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. , 2002, The Journal of rheumatology.

[174]  A. Ivinson.  Macroeconomics and Health: Investing in Health for Economic Development , 2002, Nature Medicine.

[175]  M. Drummond,et al.  Progress towards an OMERACT-ILAR guideline for economic evaluations in rheumatology , 2002, Annals of the rheumatic diseases.

[176]  E. Kulinskaya,et al.  Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS) , 2002, Annals of the rheumatic diseases.

[177]  Andrew R Willan,et al.  Is there a kink in consumers' threshold value for cost-effectiveness in health care? , 2002, Health economics.

[178]  H. Genant,et al.  Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs. , 2001, The Journal of rheumatology.

[179]  P. Gordon,et al.  A 10 year prospective followup of patients with rheumatoid arthritis 1986-96. , 2001, The Journal of rheumatology.

[180]  L. Kiemeney,et al.  The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[181]  D S Nagin,et al.  Analyzing developmental trajectories of distinct but related behaviors: a group-based method. , 2001, Psychological methods.

[182]  F. Wolfe,et al.  A reappraisal of HAQ disability in rheumatoid arthritis. , 2000, Arthritis and rheumatism.

[183]  M. Prevoo,et al.  No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset , 2000, Annals of the rheumatic diseases.

[184]  G. Wilkinson,et al.  Gender differences in depression. Critical review. , 2000, The British journal of psychiatry : the journal of mental science.

[185]  M. Dougados,et al.  Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. , 2000, Osteoarthritis and cartilage.

[186]  A. Silman,et al.  One year followup variables predict disability 5 years after presentation with inflammatory polyarthritis with greater accuracy than at baseline. , 2000, The Journal of rheumatology.

[187]  A. Silman,et al.  Associations between demographic and disease-related variables and disability over the first five years of inflammatory polyarthritis: a longitudinal analysis using generalized estimating equations. , 2000, Journal of clinical epidemiology.

[188]  P. Emery,et al.  How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS) , 2000, Rheumatology.

[189]  R. Stephens,et al.  Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[190]  A Woolf,et al.  The links between joint damage and disability in rheumatoid arthritis. , 2000, Rheumatology.

[191]  Robert L. Leahy,et al.  The Use of Psychological Testing for Treatment Planning and Outcome Assessment , 2000, Journal of Cognitive Psychotherapy.

[192]  M J Elders,et al.  The increasing impact of arthritis on public health. , 2000, The Journal of rheumatology. Supplement.

[193]  A. Brennan,et al.  Modelling in health economic evaluation. What is its place? What is its value? , 2000, PharmacoEconomics.

[194]  J. Barlow,et al.  Comparison of knowledge and psychological well-being between patients with a short disease duration (< or = 1 year) and patients with more established rheumatoid arthritis (> or = 10 years duration). , 1999, Patient education and counseling.

[195]  A. Zwinderman,et al.  Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. , 1999, Arthritis and rheumatism.

[196]  C Victor,et al.  Economic evaluation of a primary care-based education programme for patients with osteoarthritis of the knee. , 1999, Health technology assessment.

[197]  N. Aaronson,et al.  Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. , 1998, Journal of clinical epidemiology.

[198]  M Sullivan,et al.  Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. , 1998, Journal of clinical epidemiology.

[199]  D. Lubeck,et al.  Longterm health outcomes of patients with rheumatoid arthritis treated in managed care and fee-for-service practice settings. , 1998, The Journal of rheumatology.

[200]  R. Madhok,et al.  Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: results of a five year prospective study , 1998, Annals of the rheumatic diseases.

[201]  L. McCracken.  Learning to live with the pain: acceptance of pain predicts adjustment in persons with chronic pain , 1998, Pain.

[202]  R H Brook,et al.  Costs attributable to osteoarthritis. , 1998, The Journal of rheumatology.

[203]  M J Buxton,et al.  Modelling in economic evaluation: an unavoidable fact of life. , 1997, Health economics.

[204]  W M O'Fallon,et al.  Direct medical costs unique to people with arthritis. , 1997, The Journal of rheumatology.

[205]  P. Tugwell,et al.  Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III. , 1997, The Journal of rheumatology.

[206]  L. March,et al.  Economics of osteoarthritis: a global perspective. , 1997, Bailliere's clinical rheumatology.

[207]  J. Pater.  Quality of life and pharmacoeconomics in clinical trials , 1996 .

[208]  P. Tugwell,et al.  Percentile curve reference charts of physical function: rheumatoid arthritis population. , 1995, The Journal of rheumatology.

[209]  A. Young,et al.  Short-term outcomes in recent-onset rheumatoid arthritis. , 1995, British journal of rheumatology.

[210]  A. Silman,et al.  The incidence of rheumatoid arthritis in the United Kingdom: results from the Norfolk Arthritis Register. , 1994, British journal of rheumatology.

[211]  C. Bombardier,et al.  Functional disability in early rheumatoid arthritis: description and risk factors. , 1994, The Journal of rheumatology.

[212]  P. Gardiner,et al.  An evaluation of the Health Assessment Questionnaire in long-term longitudinal follow-up of disability in rheumatoid arthritis. , 1993, British journal of rheumatology.

[213]  J. Fries,et al.  Tobit, fixed effects, and cohort analyses of the relationship between severity and duration of rheumatoid arthritis. , 1993, Social science & medicine.

[214]  M. Abdalla,et al.  The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? , 1993, BMJ.

[215]  A Coulter,et al.  Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. , 1993, BMJ.

[216]  M. Ward,et al.  Marital status and the progression of functional disability in patients with rheumatoid arthritis. , 1993, Arthritis and rheumatism.

[217]  C. McHorney,et al.  The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs , 1993, Medical care.

[218]  J F Fries,et al.  Severity of disability and duration of disease in rheumatoid arthritis. , 1992, The Journal of rheumatology.

[219]  F. Wolfe,et al.  Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies. , 1992, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[220]  J. Fries,et al.  Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis. , 1992, Annals of the rheumatic diseases.

[221]  F. Guillemin,et al.  Functional disability in rheumatoid arthritis: two different models in early and established disease. , 1992, The Journal of rheumatology.

[222]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[223]  L. George,et al.  The association of age and depression among the elderly: an epidemiologic exploration. , 1991, Journal of gerontology.

[224]  F. Wolfe,et al.  Clinical and health status measures over time: prognosis and outcome assessment in rheumatoid arthritis. , 1991, The Journal of rheumatology.

[225]  F. Wolfe,et al.  The assessment and prediction of functional disability in rheumatoid arthritis. , 1991, The Journal of rheumatology.

[226]  F. Wolfe,et al.  The effect of age on methotrexate efficacy and toxicity. , 1991, The Journal of rheumatology.

[227]  A. Zwinderman,et al.  Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study. , 1991, Arthritis and rheumatism.

[228]  E. Yelin,et al.  Effect of parenterally administered gold therapy on the course of adult rheumatoid arthritis. , 1991, Annals of internal medicine.

[229]  T D Cooke,et al.  The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. , 1991, Arthritis and rheumatism.

[230]  W. Murphy,et al.  The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. , 1990, Arthritis and rheumatism.

[231]  R. Villar.  Knee replacement. , 1990, The Practitioner.

[232]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[233]  J. Kirwan,et al.  Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. , 1986, British journal of rheumatology.

[234]  J. Fries,et al.  The development of disability in rheumatoid arthritis. , 1986, Arthritis and rheumatism.

[235]  M. Hochberg,et al.  Osteoarthritis I: epidemiology. , 1984, Maryland state medical journal.

[236]  J. Fries,et al.  The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales. , 1982, The Journal of rheumatology.

[237]  H. Holman,et al.  Measurement of patient outcome in arthritis. , 1980, Arthritis and rheumatism.

[238]  J. Hearnshaw.  'Learning to live'. , 1975, Queen's nursing journal.